U.S. Congress: All 16 Cannabis Bills Filed in the 2025-2026 Session

Key Points
  • The MORE Act aims to fully deschedule marijuana federally, establish automatic expungements, create a federal excise tax, and direct revenue to community reinvestment, with 62 sponsors making it the most supported cannabis bill in 2025-2026.
  • The STATES 2.0 Act protects state-legal marijuana operations from federal enforcement, enables interstate commerce, proposes a federal regulatory framework, and has eight sponsors.
  • The Hemp Planting Predictability Act, a bipartisan bill with 36 sponsors, proposes a three-year delay on new federal hemp restrictions set for November 2025, postponing them until 2029.
  • The CLIMB Act would allow state-legal cannabis businesses to access major stock exchanges, protect ancillary service providers, preserve Section 280E tax restrictions, and has 15 sponsors across both chambers.

Sixteen bills have been filed so far during the 2025-2026 session of the United States Congress. Below is a breakdown of each one (the list does not include cannabis-related amendments filed to other bills).

The MORE Act would fully remove marijuana from the Controlled Substances Act, ending federal prohibition altogether. It also establishes automatic expungement for certain federal marijuana offenses, creates a new federal excise tax on marijuana products and directs revenue toward community reinvestment and small business programs. The bill currently has 62 sponsors, more than any other cannabis-related proposal filed in 2025 or 2026.

The STATES 2.0 Act would prohibit federal enforcement actions against individuals and businesses operating in compliance with state or tribal marijuana laws. It authorizes interstate commerce between legal jurisdictions, removes marijuana businesses from the reach of Section 280E and outlines a federal regulatory structure with relatively low tax rates. The bill has eight total sponsors.

The Hemp Planting Predictability Act is a bipartisan bill that would delay new federal hemp restrictions set to take effect this November. The House version, introduced by Representative Jim Baird (R-IN) in January, now has 33 sponsors, while a Senate companion from Senators Amy Klobuchar (D-MN), Rand Paul (R-KY) and Jeff Merkley (D-OR) brings the total to 36.

If passed, the bill would not repeal the hemp changes, but would delay them for three years, pushing implementation to November 2029.

The Capital Lending and Investment for Marijuana Businesses Act, or CLIMB Act, would allow state-legal marijuana businesses to list on major national stock exchanges such as Nasdaq and the New York Stock Exchange. Filed by Representatives Guy Reschenthaler (R-PA) and Troy Carter (D-LA), the bill would also protect a wide range of businesses and individuals that provide services to the marijuana industry.

In addition to exchange access, the measure would block federal agencies from penalizing those who work with state-legal marijuana companies, including banks, insurers, investors, accountants, attorneys, marketers, tech firms and real estate providers. It would also protect stock exchanges and other market participants that facilitate marijuana-related securities.

Rather than loosening federal tax restrictions, this bill would explicitly preserve Section 280E, which bars marijuana businesses from claiming standard business deductions, even after cannabis is officially reschedule from Schedule I to Schedule III (under current law, Section 280E applies only to substances classified as Schedule I or II). The measure has 15 total sponsors between the House and Senate.

Introduced in December 2025, the RESPECT Resolution encourages state and local governments to adopt equity-focused cannabis policies. Rather than changing federal law directly, it promotes expanded access to business opportunities, capital and economic participation for communities disproportionately impacted by past marijuana enforcement. The resolution has 11 sponsors.

The HEMP Act would revise the federal definition of legal hemp by adjusting THC thresholds and updating testing standards that currently result in frequent crop failures. It also proposes national labeling and product consistency rules aimed at stabilizing the hemp supply chain. The bill has one sponsor.

The proposal marks the third hemp-related bill filed during the 2025-2026 session, and the 15th overall cannabis-related bill.

The Marijuana in Federally Assisted Housing Parity Act of 2025 would prohibit public housing authorities and other federally assisted housing providers from denying admission to, or evicting, individuals solely for using marijuana in compliance with state law. Under current federal policy, marijuana remains prohibited in federally subsidized housing regardless of state legalization, creating conflicts for tenants in legal states. The Senate and House versions of the bill have a combined four sponsors.

This bill, which has three sponsors, would move marijuana from Schedule I to Schedule III under the Controlled Substances Act, a move already under way with the Trump Administration (President Trump signed a rescheduling executive order in December, with a final rule expected to be published by the DEA immanently).

The Cannabinoid Safety and Regulation Act (S. 3474) would create a federal framework for regulating cannabis and cannabinoid products. The measure includes provisions related to FDA oversight, product standards, labeling, testing, underage-use prevention and cannabis-impaired driving.

The American Hemp Protection Act (H.R. 6209) would repeal the federal hemp amendments enacted through Public Law 119-37. Supporters say the change would undo the newer restrictions and restore the prior legal framework for hemp.

The HEMP Act (H.R. 7212) would amend the Federal Food, Drug, and Cosmetic Act to create a federal regulatory framework for cannabinoid hemp products. Introduced by Representatives Morgan Griffith (R-VA) and Marc Veasey (D-TX), the proposal is intended to bring more federal oversight and consistency to a market currently governed largely by a patchwork of state laws.

This legislation would repeal the requirement that the Office of National Drug Control Policy oppose marijuana legalization as a matter of law. By removing that mandate, the bill would allow federal drug policy positions to be guided by scientific research and public health data rather than statutory prohibition language. The bill has two sponsors.

This measure would bar the Department of Veterans Affairs from denying benefits solely based on a veteran’s participation in a state-legal medical marijuana program. It also directs VA providers to discuss marijuana use with patients and include it in treatment planning. The bill has two sponsors.

The Veterans Equal Access Act would allow VA doctors to discuss medical marijuana with patients and complete state-required certification forms where medical marijuana is legal. The bill also has two sponsors.

The PREPARE Act directs federal agencies to begin planning for a potential post-prohibition marijuana framework. It calls for analysis of regulatory models, tax structures and public health considerations that would arise if marijuana were descheduled, without directly changing marijuana’s legal status. The bill currently has one sponsor.